Bob, you have been away from the board too long.LOL Welcome back. Wait till Cacaito sees this>>>>>>>>Cepheid and Children's Medical Center of Dallas to Develop Rapid Diagnostic Methods for Infectious Diseases in Children
SUNNYVALE, Calif., Sept. 3 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq:CPHD), today announced that it has been selected to participate in a program to develop rapid diagnostic methods for improving the diagnosis of infectious diseases in children.
The project, which is a collaborative effort including Cepheid, Children's Medical Center of Dallas and The University of Texas Southwestern Medical Center at Dallas, involves the development of rapid diagnostic test protocols, procedures, and reagents using Cepheid's Smart Cycler and GeneXpert(R) platforms. Dr. Beverly Rogers, chief of pathology at Children's and professor of pathology at UT Southwestern, is leading the program which will focus on the development of rapid nucleic acid testing methods for enterovirus and herpes simplex virus which are major causes of meningitis, and Bordetella pertussis, the bacteria that causes whooping cough. Despite immunization programs, this disease continues to be a serious health concern. The one-year Centers for Disease Control and Prevention grant to Children's Medical Center of Dallas will total $435,000, part of which will be used to purchase GeneXpert systems and cartridges.
"The GeneXpert(R) system is ideally suited to this type of test because of its speed, its automated sample processing capability, and its ability to detect multiple DNA sequences in the same reaction. Scheduled for market availability in 2003, the GeneXpert(R) is designed to provide a fully automated genetic assessment result, sample in -- answer out," said Kurt Petersen, Cepheid president and chief operating officer.
Dr. Rogers remarked, "Innovations in diagnostic testing that incorporate molecular biology into the routine care of the patient are ringing in the millennium. The Cepheid GeneXpert system is the first 'walk-away' instrument that combines all of the aspects of the PCR, so that a health-care worker can take a sample from a patient, place the sample into the instrument, and have an answer within an hour. The rapid diagnosis of childhood meningitis, sepsis, or even antibiotic resistance will soon be available in 'real-time,' that is 24 hours a day/seven days a week. There is great potential to identify infections faster, treat patients better, and save patient admissions to the hospital, resulting in cost savings to the health-care system."
About Cepheid
Cepheid, based in Sunnyvale, Calif., is a leading developer, manufacturer and marketer of fully integrated systems that enable genetic assessment when and where it is needed. Founded in 1996, the company is commercializing its technology and products worldwide for research, medical, and industrial applications requiring assessment of the human genome, infectious disease and biothreat agents. See www.cepheid.com for more information.
This press release contains forward-looking statements, including statements regarding the performance, benefits and scheduled market availability of the GeneXpert(R) system that are not purely historical regarding the company or management's intentions, beliefs, expectations and strategies for the future. Because such statements deal with future events, they are subject to various risks and uncertainties, and actual results could differ materially from the company's current expectations. Readers should refer to the section entitled "Risk Factors" in Cepheid's Annual Report on Form 10-K for 2001 and "Factors that Might Affect Future Results" in its most recent quarterly report on Form 10-Q, both of which were filed with the Securities and Exchange Commission.
All forward-looking statements and reasons why results might differ included in this release are made as of the date of this press release, based on information currently available to Cepheid, and Cepheid assumes no obligation to update any such forward-looking statement or reasons why results might differ.
MAKE YOUR OPINION COUNT - Click Here
tbutton.prnewswire.com
SOURCE Cepheid
CO: Cepheid; Children's Medical Center of Dallas; University of Texas Southwestern Medical Center at Dallas
ST: California, Texas
SU: JVN CHI
prnewswire.com
09/03/2002 07:00 EDT<<<<<<<<<<<<<<<<<<<<<<<<<<< |
